adding weight loss medications necessitates even more vigilant nutritional surveillance
According to the study authors, however, there isnt much research looking into what happens to men and their testosterone once they start taking GLP-1s like semaglutide (the active ingredient in the diabetes drug Ozempic and the obesity drug Wegovy)
Consider baseline labs (liver enzymes, kidney function, CBC) and revisit if symptoms change
In summary, while DSIP holds promise as a therapeutic agent for various conditions, its potential side effects and safety considerations must be taken into account
In this context, native GLP-1(7-36) could be regarded as natural suppressor of platelet aggregation and thrombus growth under physiological flow conditions
Another knock on Maximus quality of care is that there arent a lot of avenues to explore should certain side effects arise